Pages that link to "Q37235019"
Jump to navigation
Jump to search
The following pages link to Treatment of Hodgkin lymphoma: the past, present, and future. (Q37235019):
Displayed 39 items.
- Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma (Q33418817) (← links)
- Newly emerging therapies targeting viral-related lymphomas (Q33699201) (← links)
- Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis (Q33886243) (← links)
- Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature. (Q34085052) (← links)
- Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery (Q34104990) (← links)
- Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis (Q34284202) (← links)
- TRAIL treatment provokes mutations in surviving cells (Q34383454) (← links)
- An IL12-IL2-antibody fusion protein targeting Hodgkin's lymphoma cells potentiates activation of NK and T cells for an anti-tumor attack (Q34427113) (← links)
- Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma (Q35986604) (← links)
- FDG-PET/CT based response-adapted treatment. (Q36286595) (← links)
- Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma (Q36463861) (← links)
- The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature (Q36557304) (← links)
- Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes (Q36628641) (← links)
- Relapsed Hodgkin lymphoma: management strategies (Q37008427) (← links)
- The role of fluorodeoxyglucose positron emission tomography-computerized tomography in resolving therapeutic dilemmas in pediatric Hodgkin lymphoma (Q37058257) (← links)
- Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. (Q37216194) (← links)
- Unintended pregnancy during radiotherapy for cancer (Q37378986) (← links)
- Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin (Q37412853) (← links)
- Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis (Q38051051) (← links)
- CD30 as a therapeutic target for lymphoma (Q38138482) (← links)
- Risk-adapted strategies for the treatment of Hodgkin lymphoma (Q38591137) (← links)
- Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations. (Q38775871) (← links)
- Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma (Q38978471) (← links)
- Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma (Q39115390) (← links)
- Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma (Q41550137) (← links)
- Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma (Q42320787) (← links)
- Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988–2005: an analysis of 21 734 cases (Q43526086) (← links)
- Curing Hodgkin's lymphoma: quantity and quality. (Q48941477) (← links)
- Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes. (Q52715715) (← links)
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan. (Q53178014) (← links)
- [Hodgkin's Lymphoma] (Q82728769) (← links)
- Mechlorethamine (NTG) effects on the erythrocytic and leukocytic blood parameters during experimentally induced pleuritis in rats (Q84589697) (← links)
- Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma (Q87345549) (← links)
- LGALS3 as a prognostic factor for classical Hodgkin's lymphoma (Q87411147) (← links)
- Long-Term Survival Rates of Patients with Stage III-IV Hodgkin Lymphoma According to Age, Sex, Race, and Socioeconomic Status, 1984-2013 (Q88608611) (← links)
- [Advances and thoughts of PET-CT application in Hodgkin's lymphoma] (Q89257279) (← links)
- The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt (Q89530708) (← links)
- Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation (Q90541178) (← links)
- Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis (Q95811406) (← links)